Updated:
Avricore Health Inc.
Avricore Health Inc. is a publicly traded Canadian company (TSX-V: AVCR) that commercializes the HealthTab point-of-care testing system.
Avricore Health Inc.
Avricore Health Inc. is a publicly traded Canadian company (TSX-V: AVCR) that commercializes the HealthTab point-of-care testing system. The platform allows community pharmacists to conduct finger-prick blood tests for conditions such as diabetes, cholesterol, and heart disease, with results integrated into provincial health records. The firm's business model centers on selling test cartridges and a subscription-based cloud data service. The HealthTab system is deployed in over 500 pharmacies across Canada, primarily in British Columbia and Alberta, with expansion into Ontario. Avricore's technology partners include Abbott Laboratories, which supplies the i-STAT Alinity point-of-care analyzer. The firm has raised capital through private placements and public offerings on the TSX Venture Exchange. Avricore is led by CEO Michael G. Singer and maintains a lean operational team. The company has not disclosed ownership breakdown, headcount, or AUM. It operates as a standalone public entity rather than a family office.The firm's structural differentiator is its focus on regulatory compliance and interoperability with Canadian provincial health systems, requiring proprietary data integration software rather than just hardware sales.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
—
Country
—
City
—
Corporate office
—
Sector focus
Frequently asked questions
What is HealthTab and how does it work?
HealthTab is a point-of-care testing platform developed by Avricore Health. Pharmacists use it to perform finger-prick blood tests, with results shared securely with patients and their physicians via provincial electronic health records.
Does Avricore Health operate as a family office?
No. Avricore Health Inc. is a publicly traded company on the TSX Venture Exchange (AVCR). It does not function as a family office, asset manager, or investment vehicle.
Who leads Avricore Health?
Michael G. Singer serves as CEO. The firm's board includes directors with backgrounds in health technology and capital markets, per public filings.
Where is Avricore Health headquartered?
The company is based in Vancouver, British Columbia, Canada, per TSX filings. No additional office locations have been disclosed.
What is Avricore Health's investment history?
Avricore has raised capital through public offerings and private placements on the TSX Venture Exchange. Specific amounts and valuations are disclosed in SEDAR filings.
How does Avricore Health generate revenue?
Revenue comes from sales of test cartridges for the HealthTab platform and subscription fees for the cloud-based data service. The firm does not disclose detailed financials beyond regulatory filings.
Is Avricore Health profitable?
Profitability status is not publicly disclosed in a clear format. Investors should refer to the company's most recent financial statements on SEDAR.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: